FDA Inspection 1153137 — Sabine S. Hazan, M.D.

Sabine S. Hazan, M.D. — FEI 3016661283

The FDA completed an inspection of Sabine S. Hazan, M.D. on September 21, 2021 in Ventura, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
September 21, 2021
Fiscal Year
2021
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Ventura, CA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
751721 CFR 312.66Initial and continuing review
756021 CFR 312.60FD-1572, protocol compliance
756221 CFR 312.60Informed consent